Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00032500 · ClinicalTrials.gov registry record · Phase 2
Evaluation of Echinacea for the Common Cold
A Phase 2 study, sponsored by National Center for Complementary and Integrative Health (NCCIH).
- Completed
- Registry status
- Phase 2
- Development phase
NCT00032500 is a Phase 2 study that has completed, run by National Center for Complementary and Integrative Health (NCCIH).
The verdict
NCT00032500, a Phase 2 study, has completed, sponsored by National Center for Complementary and Integrative Health (NCCIH).
- COMPLETED
- Registry status
- Phase 2
- Development phase
Study Summary
The purpose of this study is to determine whether three Echinacea preparations with different chemical compositions are effective for prevention or treatment of the common cold.
Interventions
- DRUG Echinacea
Trial Details
| Field | Value |
|---|---|
| Start Date | 2001-09 |
| Est. Completion | 2004-05 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00032500
The ClinicalTrials.gov registry entry for NCT00032500 describes a study currently listed as completed, categorized as Phase 2. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is National Center for Complementary and Integrative Health (NCCIH), which has 203 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Echinacea is the first listed.
NCT00032500 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00032500 about?
NCT00032500 is a clinical study titled "Evaluation of Echinacea for the Common Cold". The purpose of this study is to determine whether three Echinacea preparations with different chemical compositions are effective for prevention or treatment of the common cold.
What is the current status of trial NCT00032500?
This trial is currently completed. It is a Phase 2 study. The study started on 2001-09. Estimated completion is 2004-05.
What interventions are being tested in trial NCT00032500?
The interventions under investigation include: Echinacea (DRUG).
Who is sponsoring clinical trial NCT00032500?
This trial is sponsored by National Center for Complementary and Integrative Health (NCCIH), which has 203 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.